HOME JOURNALS CONTACT

Journal of Biological Sciences

Year: 2008 | Volume: 8 | Issue: 2 | Page No.: 242-247
DOI: 10.3923/jbs.2008.242.247
Phytotherapy in Cardiovascular Diseases: From Ethnomedicine to Evidence Based Medicine
Ovidiu Burta, Felicia Tirlea, Olivia Ligia Burta and Syed Minnatullah Qadri

Abstract: Cardiovascular diseases are now considered to be one of the major causes of mortality in the developed and developing world. With the advent of better diagnostic procedures and therapeutic strategies their management has become more efficient, yet the role of herbal and plant remedies is paramount in the developing and remote areas of the world. Phytotherapy or therapeutics using plants and herb based compounds or crude drugs are an indispensable part of Complementary and Alternative Medicine (CAM). The benefits of most of these plants are controversial as their toxicology and pharmacological activities are not well studied and documented. However certain plants species like Ginko biloba and Crataegus have shown promise in experimental and clinical trials. In the present review, some anthropo-geographical and historical perspectives of phytotherapy are mentioned. Some important manifestations of cardiovascular pathology and their phytotherapy are reviewed. The holistic approach of phytotherapy and folkloric ethno medical practices indeed have opened new horizons for quality care in cardiovascular diseases. Phytotherapy and traditional medicine have proven their potential place in the modern and more skeptical evidence based medicine.

Fulltext PDF Fulltext HTML

How to cite this article
Ovidiu Burta, Felicia Tirlea, Olivia Ligia Burta and Syed Minnatullah Qadri, 2008. Phytotherapy in Cardiovascular Diseases: From Ethnomedicine to Evidence Based Medicine. Journal of Biological Sciences, 8: 242-247.

Keywords: evidence based medicine, folk medicine, phytotherapy, Cardiovascular diseases, herbal medicine and ethnopharmacology

INTRODUCTION

Since time immemorial, disease has threatened the integrity and socio-economic welfare of humans. In every era and in every era of every community humans took up the challenge of seeking the cure for disease in the surrounding nature. The advent of traditional and nature based medicine thus improved the quality of lives and facilitated the lengthening of life spans. Traditional medicine continues till the present day to form an integral part of human cultures in many remote and under developed parts of the globe where it is the conventional form of health care. The geo-anthropological and floral diversity is a major factor in the vast array of ethno-medicine and traditional herbal and natural therapies.

The current system of health care in developed countries is steadily incorporating phytotherapy in pharmacotherapy predominantly based on synthetic drugs. With advances in pharmacognosy and experimental pharmacology the toxicological and therapeutic potential of drugs has become easier to determine. Phytotherapy is now an important domain of the complementary and alternative form of medicine. Complementary and alternative medicine is widely used in the developed world (Eisenberg et al., 1998). Complementary and Alternative Medical (CAM) practices are those health care and medical practices that are not currently an integral part of conventional medicine and not routinely taught in western medical schools (Eisenberg et al., 1993). CAM therapies broadly include yoga, relaxation/hypnosis, acupuncture, spiritual healing, chiropractic care, massage and nutrition and naturopathic remedies. CAM therapy use increased 25% and the number of Americans taking herbs nearly quadrupled (Eisenberg et al., 1998; Miller et al., 2004). In a broader sense traditional medicine and CAM are described as Hippocratic, holistic, integrative and preventive where as, conventional medicine is considered Gaelenic, analytical, curative and specific (Fulder and Munro, 1985). Some current terms associated with CAM are: folkloric, holistic, integrative, traditional, unorthodox, unconventional, unofficial, natural, mind-body etc., but there are certain more assertive terms like ineffective, questionable, dubious etc. (McGinnis, 1991). There is just as much evidence in favor of CAM as there is against it (Syed Minnatullah Qadri, 2001).

ANTHROPO-GEOGRAPHICAL AND HISTORICAL USE OF MEDICINAL PLANTS

The evidence of the use of plants for medicinal purposes dates as far back as 60,000 years ago, in both Western and Eastern cultures and in both developed and undeveloped countries (Gossel et al., 2006). The Egyptian pharmacopoeia of Ebers Papyrus, written about 1500 BC, documents the use of medicinal plants such as the poppy of opium oil and the oil of castor beans (Ackernecht, 1973). The Indian subcontinent has witnessed the growth of two of very important systems of medicine Ayurvedic and Unani (Greco-Arabic) medicine, related but distinct in many ways. They have a standardized pharmacopoeia of herbal and natural crude drugs. Both these systems still flourish in modern times and have been widely adapted as Oriental/Eastern medicine along with Chinese medicine. There has been an upsurge in demand for the Phyto-pharmaceutical products of Ayurveda in western nations, because of the fact that the synthetic drugs are considered to be unsafe (Said, 1977; Subhose et al., 2005). Several herbs described in the Chinese folklore are presently used in the Chinese herbal system of medicine popularly known as Traditional Chinese Medicine (TCM). The Chinese materia medica comprises herbal formulations and other crude drugs used in various diseases (Zhu et al., 2007). Human beings have been involved in plant derived medicine or herbal medicines since prehistoric times. Herbal medicine and phytotherapy has enabled scientists to make many contributions to commercial drug preparations manufactured today (Yilmaz et al., 2006).

The role of CAM in general and phytotherapy in various diseases in particular has been of extreme interest to various scientific and non scientific communities throughout the world. Phytotherapy is broadly defined as the use of natural therapeutic agents derived from plants or crude herbal drugs.

Cardiovascular diseases are now considered a major cause of mortality in not only the developed world but also in the developing countries. In the age of genomics, nanotechnology and proteomics, cardiovascular diseases continue to remain a major challenge to therapeutically manage and the search for a viable evidence-based alternative continues (Burta et al., 2007).

Folk and ethno medicine records have been of extreme value in this regard. In 350-377 BC, Hippocrates, the father of medicine, advised the use of diet and plant medicines. He tried to relieve the pain of his patients by asking them to chew Willow bark, which contains salicylic acid. Long before Hippocrates, the ancients Egyptians, Sumerians, Indians and Chinese were noted to use herbs such as onions, garlics, ginger, thyme etc. In 1775, it is reported that William Withering cured people with dropsy, swelling of the legs and shortness of breath related to heart failure with a herbal poly formulation that also contained fox glove plant, Digitalis purpurea. Since then for more than 200 years digitalis (digoxin) has been used to treat cardiac insufficiency (DeSmet, 2002).

Avicenna in about 1000 AD, in his pioneering work. The Canon of Medicine, logically and scientifically presented perhaps for the first time in the history of medicine through a classified description of cardiac diseases. He was inspired by the earlier works of Greek scholars, Aristotle and Galen. He is considered the first physician to correlate the diseases of the heart with the temperament and psychic make up of an individual and wrote an elaborate pharmacopoeia on heart remedies (Said, 1995).

The Ayurvedic treatment practiced since ancient times in the India consists of the use herbal preparations, diet, yoga, meditation and other practices. Studies have shown that the dietary principles and herbal formulations have a positive impact on cardiovascular diseases like essential hypertension, dyslipidemia and cardiac insufficiency (Mamtani, 2005). The Chinese system of medicine popularly known as Traditional Chinese Medicine or TCM has been very successful in the phytotherapy of cardiovascular diseases. Acupuncture along with TCM is beneficial as an adjunctive therapy in the management of congestive heart failure, arrhythmias and systemic hypertension (Smith, 1992).

CARDIOVASCULAR PATHOLOGY AND PHYTOTHERAPY

Cardiovascular diseases are a broad entity including all diseases that affect the circulation of blood and distribution of oxygen to healthy tissues. They include ischemic cardiopathy, hypertension, hypotension, conduction defects and arrhythmias, valve defects and an eventual dysfunction known as heart failure (Burta et al., 1998). The phytotherapy of cardiovascular diseases is always set with pros and cons just like any other pharmacotherapy. With years of research and clinical trials, many plants have been approved by various drug associations and commercially marketed for treating heart and circulation diseases. Majority of these drugs owe their origins to the traditional and folkloric practices where they were accidentally discovered and through trial and error have been used for centuries (Zbiden et al., 2002). The discussion about the benefit of these drugs is still controversial because of lack of scientific evidence. However, certain drugs like Ginko biloba, Crataegus and garlic, often recommended substances for patients with cardiovascular diseases. For these substances there is a lot of data available from experimental and clinical studies, unfortunately not always adhering to the criteria of evidence based medicine (Dennehy, 2001). The present review encompasses of succinct outlines of some common plants used in the pharmacotherapy of various cardiovascular ailments consisting of both drugs used in traditional medicine worldwide and under experimental and clinical studies but also clinically approved herbs that have proven to be evidenced based medicine.

PHYTOTHERAPY IN ISCHEMIC HEART DISEASE, PLATELET AGGREGATION AND HYPERLIPIDEMIA

Diseases that cause the ischemia of the myocardium are potentially fatal. They belong to the wider class of acute coronary syndromes. In modern day medicine they are well managed by vasodilators and nitroglycerine compounds, calcium channel blockers and beta blockers that are regarded as the cornerstone of cardiac therapy (Khan, 1999). Arnica montana is often described for anti-inflammatory activities but there are strong suggestions made in literature regarding its anti anginal activity. The flavonoids of these compounds are suggested for its activity against coronary insufficiency. The pharmacological activity of Arnica is well recorded in homeopathic tinctures (Rutten, 2004). Danshen (Salvia miltiorrhiza) is believed to posses’ vasoactive free radical scavenger and demonstrable properties. Because of its properties of improving microcirculation, causing coronary vasodilatation, suppressing the formation of thromboxane, inhibiting platelet adhesion and aggregation and protecting against myocardial ischemia, it is widely used either alone or in combination with other herbal ingredients for patients with coronary artery disease and other cardiovascular diseases especially in China (Tsung, 2006, 2007).

Garlic (Allium sativum) and its supplements are considered to outnumber any other supplements in the pharmaceutical market sales and consumption by the general population (Radimer et al., 2000). It is believed to reduce cholesterol, decrease blood pressure, inhibit atherosclerosis and improve circulation. Since hyperlipidemia is directly associated to atherosclerosis and coronary heart disease. Drugs improving the lipid profiles help against atherosclerosis (Burta et al., 2000a, b). The active substance is allicin, formed by the action of alliinase on alliin when crushed (Ali et al., 2000). A trial of garlic versus fibrates reported similar efficacy. Both forms of treatments produced parallel reductions in Low-Density Lipoprotein (LDL) and increases in High-Density Lipoprotein (HDL) cholesterol, thus remarkably reducing the risk of an acute coronary event (Stevinson et al., 2000; Holzgartner et al., 1992). Other plants with potential against ischemic heart disease currently under pharmacognostical and ethnopharmacological study worldwide and used by indigenous folk medical practitioners include, coronary dilators like Coffeae semen, Cacao semen, Theae folium, Gurana (soft extract of Paullina cupana seeds) and antispastic agents such as Ammi visagnae fructus, volatile oils containing methyl salicyclates like Betulae lentae aertherleum and Ulmariae herba (Duarte et al., 1999; Zambel et al., 2006; Lee et al., 2003). Olea europaea or olive is now known to reduce the risk of coronary heart disease and is more of a dietary therapy than an exclusive phytotherapy (Caramia, 2006). Avena sativa, Amaranthus hypochondriacus and red grapefruit are all known to be beneficial against coronary artery disease (Cerwiñski et al., 2004). For the treatment of coagulation imbalance related to atherosclerosis and coronary artery diseases certain plants like Allium sativum, Ginko biloba, Salvia miltiorrhiza, Zingiber officinale, Angelicae sinensis (Dong Quai) etc. are known to inhibit platelet aggregation and are beneficial in patients with acute coronary syndromes (Tsung, 2007; Burta, 2000b; Grant and Lutz, 2000; Diamond et al., 2000). Ginko biloba is a strong anti oxidant and has a strong free radical scavenging properties. It has the propensity for protection to reperfusion injury and markers of oxidative stress and cardiac performance, including cardiac index and left ventricular stroke volume improved after surgical intervention on the heart (Diamond et al., 2000).

ARTERIAL HYPERTENSION AND PHYTOTHERAPY

Treatment of hypertension has been a major accomplishment of phytotherapy. There are several studies to substantiate the anti hypertensive effects of drugs used in ethnomedicine and folk practitioners. Some of the well elaborated and studied crude herbal drugs are derived from the Chinese, Ayurvedic and Unani systems of Eastern and oriental medicine. Reserpine, the purified alkaloid of Rauwolfia serpentina, was the first potent drug widely used in the long-term treatment of hypertension. It was used as an integral part of the Indian folk medicine in Ayurveda and Unani. There have also been reports that it was used by the indigenous Indian population of India and Africa for other ailments like insomnia and snake bites (Jerie, 2007).

Ajmaline from Rauwolfia is of application in Brugada syndrome in modern cardiology (Satish et al., 2005). Hibiscus sabdarifa is an extensively studied plant for anti hypertensive effects. Traditionally it is used in West African Countries. In comparison to captopril, the anti hypertensive effects were almost similar (41). Allium sativum due to its versatile effects can be considered as the wonder herb for cardiovascular diseases. Besides its hypoglycemic, hypolipidemic and anti platelet aggregant activity, it has also anti hypertensive activity (Etuk, 2006; Ernst, 1987). Vitex dodiana is widely used in Nigerian and west African folk medicine (Etuk, 2006). Lepidium latifolium is used by the indigenous population of the Canary islands and has a major anti hypertensive effect due to its diuretic activity in rats (Navorro et al., 1994). Other herbs popular as folk remedies for hypertension and with proven ethnopharmacology include Phyllanthus amarus, Cassia occidentalis, Musanga cecropiodes, Rhapetalum coriaceum etc. (Etuk, 2006).

PHYTOTHERAPY OF CARDIAC INSUFFICIENCY

Heart failure is categorized by a decrease in the inotropic activity of the heart along together with a substantial decrease in cardiac output and a generalized edema of the body due to the pathophysiology of the renin-angiotensin-aldosternone system. Phytotherapy is the cornerstone of heart failure treatment as the first line drugs of heart failure digoxin is a plant derivative. It is inappropriate to include it anymore as CAM. Cardiotonic and diuretic based phytotherapy is essential in the treatment of congestive heart failure. One very important plant with high potential in phytotherapy and tinctures in homeopathy is Hawthorn (Crataegus species). Hawthorn berries were reportedly used by the folk medicine in North America and Europe (Valli and Giardina, 2002). Mechanisms of action of Crataegus species include antioxidant, antihyperlipidemic, vasodilatory, inotropic and decreased capillary permeability. Clinical trials have decreased symptoms of congestive heart failure, as well as improved cardiac performance (Weikl et al., 1996; Leuchtgens, 1993).

Ginko biloba is yet another drug with multi-potential in cardiovascular diseases. Ginko biloba has been reportedly used by the Chinese for more than 3000 years and it is one of the best selling natural drugs in the US. Ginko is believed to be rich in flavonoids and terpenoids which exert their effects through radical scavenging, anti platelet aggregation and anti inflammatory activities. In a study conducted with poly herbal Chinese formulation in which Ginseng was a part revealed that there was an improvement in stroke volume and cardiac index (Fang et al., 1987).

ANTI ARRHYTHMIC AND ANTI HYPOTENSIVE PHYTOTHERAPY

Anti arrhythmic therapies in conventional cardiology are by drugs derived from plants like digoxin and quinidine. So they are exclusive of CAM. Ajmaline is used in Brugada syndrome (Satish et al., 2005). Ephedrine obtained from Ma Huang has potent sympathomimetic activity and is anti hypotensive nature (White et al., 1997).

PHYTOTHERAPY IN INTERMITTENT CLAUDICATION AND CHRONIC VENOUS INSUFFICIENCY

Ginko biloba has yet another benefit in the long term treatment of intermittent claudication of the limbs due to ischemia via vasoregulation. It increased the pain free walking distance for patients dramatically (Fang et al., 1987). Horse chestnut seed or Aesculus hippocastanum, is now marketed as a phyto therapeutic product useful in chronic venous insufficiency of the lower limbs together with varicose veins. The active compound Aescin decreases lower extremity edema by decreasing capillary permeability via inhibition of endothelial lysosomal enzymes (Pittler and Ernst, 1998).

CONCLUSION

CAM in general and phytotherapy in particular have heralded a new era in cardiology by bringing hope with a more efficient management of heart and circulatory diseases. The physicians and health care providers must opt for a more holistic approach in their practice and judgment of therapeutics. CAM continues to grow world wide regardless of he economic and social status of nations. The future is steadily embracing the legacies of our ancestors and folk medicine would some day be equated to evidence based medicine. Alternative therapies give hope to the sufferers and ethnopharmacological research should play a pivotal role in heart diseases. The phytotherapy of various heart diseases has gone a long way from folklore to the present era of evidence based medicine.

REFERENCES

  • Ackernecht, E.H., 1973. Therapeutics From the Primitives to the 20th Century. Hafner Press, New York


  • Ali, M., M. Thomson and M. Afzal, 2000. Garlic and onions: Their effects on eicosanoid metabolism and its clinical relevance. Prostaglandins Leukot Essent Fatty Acids, 62: 55-73.
    CrossRef    Direct Link    


  • Burta, O., 1998. The vasodilating effect of nitrocompounds correlated with the dynamic of carbonic anhydrase isoenzymes (CA-1 and CA-2) activity in erythrocytes. Pathophysiology, 5: 15-15.


  • Burta, O., A. Lazar, A. Salajan, M. Popescu, V. Popa and F. Maghiar, 2000. Correlation between the number of risk factors and the occurrence of acute coronarian events-An epidemiological study in 1200 patients from North-Western Transilvania. Atherosclerosis, 151: 141-141.
    Direct Link    


  • Burta, O., A. Lazar, A. Salajan, L. Gilau, O. Burta and V. Salajan, 2000. Beneficial effects of combined treatment statins-antioxidant agents in patients with multiple coronary risk factors-Epidemiological study. Atherosclerosis, 151: 107-107.
    Direct Link    


  • Burta, O., S.M. Qadri and O.L. Burta, 2007. Clinical significance of the biomarker C-reactive protein in acute myocardial infarction: A preliminary laboratory evaluation. Res. J. Biol. Sci., 2: 718-721.
    Direct Link    


  • Caramia, G., 2006. Virgin olive oil. From legend to scientific knowledge of the nutraceutical aspects. Pediatr. Med. Chir., 28: 9-23.
    Direct Link    


  • Czerwinski, J., E. Bartnikowska, H. Leontowicz, E. Lange and M. Leontowicz et al., 2004. Oat (Avena sativa L.) and amaranth (Amaranthus hypochondriacus) meals positively affect plasma lipid profile in rats fed cholesterol-containing diets. J. Nutr. Biochem., 15: 622-629.
    CrossRef    


  • Dennehy, C., 2001. Botanicals in cardiovascular heath. Clin. Obstet. Gynecol., 44: 814-823.
    PubMed    


  • De Smet, P.A.G.M., 2002. Herbal remedies. N. Engl. J. Med., 347: 2046-2056.
    CrossRef    Direct Link    


  • Diamond, B.J., 2000. Ginko biloba extract: Mechanisms and clinical indications. Arch. Phys. Med. Rehabil., 81: 668-678.
    Direct Link    


  • Duarte, J., 1999. Effects of visnagin on cyclic nucleotide phosphodiesterases and their role in its Inhibitory effects on vascular smooth muscle contraction. General Pharmacol., 32: 71-74.
    CrossRef    PubMed    


  • Eisenberg, D.M., R.C. Kessler, C. Foster, F.E. Norlock, D.R. Calkins and T.L. Delbanco, 1993. Unconventional medicine in the United States: Prevalence, costs and patterns of use. N. Eng. J. Med., 328: 246-252.
    PubMed    Direct Link    


  • Eisenberg, D.M., R.B. Davis, S.L. Ettner, S. Wilkey, M. van Rompay and R.C. Kessler, 1998. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. J. Am. Med. Assoc., 280: 1569-1575.
    PubMed    Direct Link    


  • Ernst, E., 1987. Cardiovascular effects of garlic (Allium sativum): A review. Pharmatherapeutica, 5: 83-89.
    PubMed    


  • Etuk, E.U., 2006. A review of medicinal plants with hypotensive or antihypertensive effects. J. Med. Sci., 6: 894-900.
    CrossRef    Direct Link    


  • Fang, J., J. Jiang and D.C. Luo, 1987. [Effect of sheng mai decoction on left ventricular function in patients with coronary heart disease. A randomized, double-blind, placebo-controlled, cross-over trial]. Zhonghua Nei Ke Za Zhi, 26: 403-406, (In Chianese).
    PubMed    


  • Fulder, S.J. and R.E. Munro, 1985. Complementary medicine in the United Kingdom: Patients, practitioners and consultations. Lancet, 326: 542-545.
    CrossRef    Direct Link    


  • Gossel, W.M., O.R. Simor and M.E. West, 2006. The past and present use of plants for medicines. West Indian Med. J., 55: 217-218.
    PubMed    


  • Grant, K.L. and R.B. Lutz, 2000. Ginger. Am. J. Health Syst. Pharm., 57: 945-947.
    Direct Link    


  • Holzgartner, H., U. Schmidt and U. Kuhun, 1992. Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate. Arzneimittel-Forschung, 42: 1473-1477.
    PubMed    


  • Jerie, P., 2007. Milestones of cardiovascular therapy. Reserpine. Cas Lek Cesk., 146: 573-577.
    PubMed    


  • Khan, G., 1999. Cardiac Drug Therapy. Saunders Publishers, USA


  • Osman, H., R. Nasarudin and S.L. Lee, 2004. Extracts of cocoa (Theobroma cacao L.) leaves and their antioxidation potential. Food Chem., 86: 41-46.
    CrossRef    Direct Link    


  • Leuchtgens, H., 1993. [Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study]. Fortschritte der Medizin, 111: 352-354.
    PubMed    


  • Mamtani, R., 2005. Ayurveda and yoga in cardiovascular diseases. Cardiol. Rev., 13: 155-162.
    Direct Link    


  • McGinnis, L.S., 1991. Alternative Therapies. Cancer, 67: 1788-1792.


  • Miller, K.L. and S.R. Liebowitz, 2004. Complementary and alternative medicine in cardiovascular disease: A review of biologically based approaches. Am. Heart J., 147: 401-411.
    Direct Link    


  • Navarro, E., J. Alonso, R. Rodriguez, J. Trujillo and J. Boada, 1994. Diuretic action of an aqueous extract of Lepidium latifolium L. J. Ethnopharmacol., 41: 65-69.
    CrossRef    Direct Link    


  • Pittler, M.H. and E. Ernst, 1998. Horse-chestnut seed extract for chronic venous insufficiency: A criteria-based systematic review. Arch. Dermatol., 134: 1356-1360.
    CrossRef    Direct Link    


  • Radimer, K.L., A.F. Subar and F.E. Thomson, 2000. Nonvitamin, nonmineral dietary supplements: Issues and findings from NHANES III. J. Am. Dietetic Assoc., 100: 447-454.
    CrossRef    Direct Link    


  • Rutten, L., 2004. The benefits of arnica. Homeopathy, 93: 63-63.


  • Said, M., 1977. Greco-Arabic and modern Western Medicine: Conflict or symbiosis. Stud. Philos. Med., 1: 50-57.
    PubMed    


  • Said, M., 1995. Ibn-Sina's concept of cardiovascular diseases. Bull. Indian Inst. Hist. Med., 25: 129-134.
    Direct Link    


  • Satish, O.S., K.H. Yeh and M.S. Wen, 2005. Brugada syndrome: An update. Chang Gung Med. J., 28: 69-76.
    Direct Link    


  • Smith, F.W. Jr., 1992. Acupuncture for cardiovascular disorders. Probl. Vet. Med., 4: 125-131.
    PubMed    


  • Stevinson, C., M.H. Pittler and E. Ernst, 2000. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann. Intern. Med., 19: 420-429.
    PubMed    


  • Subhose, V., P. Srinivas and A. Narayana, 2005. Basic principles of pharmaceutical science in Ayurveda. Bull. Indian Inst. Hist. Med. Hyderabad, 35: 83-92.
    PubMed    


  • Syed Minnatullah Qadri, 2001. Traditional medicine: Growing trends and status. Proceedings of the 12th European Students Conference Berlin, November 20-25, 2001, Germany, pp: 160-161.


  • Tsung, O.C., 2006. Danshen: A versatile Chinese herbal drug for the treatment of coronary heart disease. Int. J. Cardiol., 113: 437-438.
    Direct Link    


  • Tsung, O.C., 2007. Cardiovascular effects of Danshen. Int. J. Cardiol., 121: 9-22.
    Direct Link    


  • Valli, G. and E.G. Giardina, 2002. Benefits, adverse effects and drug interactionsof herbal therapies with cardiovascular effects. J. Am. Coll. Cardiol., 39: 1083-1095.
    Direct Link    


  • Weikl, V.A., 1996. Crataegus special extract WS 1442: Assessment of objective effectiveness in patients with heart failure. Fortscr. Med., 114: 291-296.
    PubMed    


  • White, L.M., S.F. Gardner, B.J. Gurley, M.A. Marx, P.L. Wang and M. Estes, 1997. Pharmacokinetics and cardiovascular effects of ma‐huang (Ephedra sinica) in normotensive adults. J. Clin. Pharm., 37: 116-122.
    CrossRef    Direct Link    


  • Yilmaz, M.B., O.C. Yontar, O.O. Turgut, A. Yilmaz, K. Yalta, M. Gul and I. Tandogan, 2007. Herbals in cardiovascular practice: Are physicians neglecting anything? Int. J. Cardiol., 122: 48-51.
    CrossRef    Direct Link    


  • Zambel, A., 2006. Tu-P7: 140 Paullina pinnata extracts rich in polyphenol promote vascular relaxation via endothelium-dependent mechanisms. Atherosclerosis Supplements, 7: 215-216.


  • Zbiden, S. and C.H. Seiler, 2002. Phytotherapy in cardiovascular medicine. Ther. Umsch., 6: 301-306.
    Direct Link    


  • Zhu, M., J. Gong and Y. Liu, 2007. On the natural medical features of traditional Chinese medicine. J. Tradit. Chin. Med., 27: 158-160.
    PubMed    

  • © Science Alert. All Rights Reserved